Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

L-Arginine and Endothelial Dysfunction in Type 2 Diabetic Patients

NCT00902616 is registered in ClinicalTrials.gov with Tameside Hospital NHS Foundation Trust as lead sponsor.

NCT NCT00902616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00902616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
L-Arginine and Endothelial Dysfunction in Type 2 Diabetic Patients
Lead sponsor
Tameside Hospital NHS Foundation Trust
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
June 30, 2006
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes